| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 0 | 0 | 550 | 123 | 0 | 1.034 | 35.997 | 13.996 |
| Total Income - EUR | - | - | 0 | 3.581 | 5.818 | 5.292 | 5.054 | 1.034 | 41.121 | 19.048 |
| Total Expenses - EUR | - | - | 695 | 13.374 | 15.759 | 11.607 | 6.589 | 5.706 | 6.433 | 9.396 |
| Gross Profit/Loss - EUR | - | - | -695 | -9.793 | -9.941 | -6.316 | -1.536 | -4.672 | 34.688 | 9.652 |
| Net Profit/Loss - EUR | - | - | -695 | -9.793 | -9.949 | -6.319 | -1.536 | -4.703 | 29.139 | 8.302 |
| Employees | - | - | 0 | 2 | 2 | 2 | 2 | 2 | 1 | 1 |
Check the financial reports for the company - Dermeconomix S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 39.396 | 33.365 | 27.564 | 21.899 | 16.898 | 11.793 | 6.701 |
| Current Assets | - | - | 1 | 2 | 0 | 0 | 42 | 111 | 3.040 | 11.015 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 0 | 0 | 0 | 0 | 25 | 25 | 334 | 9.118 |
| Cash | - | - | 1 | 2 | 0 | 0 | 18 | 86 | 2.706 | 1.897 |
| Shareholders Funds | - | - | -651 | -10.432 | -20.179 | -26.116 | -27.072 | -31.859 | 2.430 | 10.718 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 652 | 10.434 | 20.179 | 26.116 | 27.115 | 26.901 | 610 | 297 |
| Income in Advance | - | - | 0 | 39.396 | 33.365 | 27.564 | 21.899 | 21.967 | 11.793 | 6.701 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dermeconomix S.r.l.